SofWave Medical Statistics

Total Valuation

SofWave Medical has a market cap or net worth of ILS 554.17 million. The enterprise value is 480.52 million.

Market Cap	554.17M
Enterprise Value	480.52M

Important Dates

The next estimated earnings date is Thursday, May 8, 2025.

Earnings Date	May 8, 2025
Ex-Dividend Date	n/a

Share Statistics

SofWave Medical has 35.23 million shares outstanding. The number of shares has increased by 0.53% in one year.

Current Share Class	n/a
Shares Outstanding	35.23M
Shares Change (YoY)	+0.53%
Shares Change (QoQ)	+0.46%
Owned by Insiders (%)	35.92%
Owned by Institutions (%)	16.29%
Float	14.19M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.55
PB Ratio	6.20
P/TBV Ratio	6.20
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-29.02
EV / Sales	2.21
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-49.36

Financial Position

The company has a current ratio of 2.22, with a Debt / Equity ratio of 0.06.

Current Ratio	2.22
Quick Ratio	1.81
Debt / Equity	0.06
Debt / EBITDA	n/a
Debt / FCF	-0.52
Interest Coverage	-63.93

Financial Efficiency

Return on equity (ROE) is -17.87% and return on invested capital (ROIC) is -8.35%.

Return on Equity (ROE)	-17.87%
Return on Assets (ROA)	-5.17%
Return on Invested Capital (ROIC)	-8.35%
Return on Capital Employed (ROCE)	-14.02%
Revenue Per Employee	1.72M
Profits Per Employee	-131,412
Employee Count	126
Asset Turnover	1.38
Inventory Turnover	2.67

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -17.64% in the last 52 weeks. The beta is 0.58, so SofWave Medical's price volatility has been lower than the market average.

Beta (5Y)	0.58
52-Week Price Change	-17.64%
50-Day Moving Average	1,626.48
200-Day Moving Average	1,698.37
Relative Strength Index (RSI)	52.05
Average Volume (20 Days)	20,912

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SofWave Medical had revenue of ILS 217.27 million and -16.56 million in losses. Loss per share was -0.48.

Revenue	217.27M
Gross Profit	164.61M
Operating Income	-13.04M
Pretax Income	-14.77M
Net Income	-16.56M
EBITDA	-8.10M
EBIT	-13.04M
Loss Per Share	-0.48

Full Income Statement

Balance Sheet

The company has 78.73 million in cash and 5.08 million in debt, giving a net cash position of 73.65 million or 2.09 per share.

Cash & Cash Equivalents	78.73M
Total Debt	5.08M
Net Cash	73.65M
Net Cash Per Share	2.09
Equity (Book Value)	89.33M
Book Value Per Share	2.53
Working Capital	77.59M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -8.73 million and capital expenditures -1.01 million, giving a free cash flow of -9.74 million.

Operating Cash Flow	-8.73M
Capital Expenditures	-1.01M
Free Cash Flow	-9.74M
FCF Per Share	-0.28

Full Cash Flow Statement

Margins

Gross margin is 75.77%, with operating and profit margins of -6.00% and -7.62%.

Gross Margin	75.77%
Operating Margin	-6.00%
Pretax Margin	-6.80%
Profit Margin	-7.62%
EBITDA Margin	-3.73%
EBIT Margin	-6.00%
FCF Margin	n/a

Dividends & Yields

SofWave Medical does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.53%
Shareholder Yield	-0.53%
Earnings Yield	-2.99%
FCF Yield	-1.76%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

SofWave Medical has an Altman Z-Score of 5.14.

Altman Z-Score	5.14
Piotroski F-Score	n/a